Picard Medical, Inc. (PMI)

Picard Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-27	-21.06	-15.57	-11.17
Depreciation & Amortization	0.16	0.23	0.59	0.55
Stock-Based Compensation	0.75	0.89	0.13	0.15
Other Adjustments	13.61	7.11	0.94	1.68
Change in Receivables	-0.12	0.12	0.25	0.21
Changes in Inventories	0.39	-1.33	-0.45	-1.59
Changes in Accounts Payable	-3.21	2.21	1.61	0.11
Changes in Accrued Expenses	0.36	0.35	1.75	-0.26
Changes in Other Operating Activities	-0.62	-0.38	0.12	-0.39
Operating Cash Flow	-15.67	-11.87	-10.63	-10.72
Capital Expenditures	-	-	-0.01	-0.03
Other Investing Activities	-	-	-0	-0.01
Investing Cash Flow	-	-	-0.01	-0.04
Long-Term Debt Issued	19.41	13.12	9.08	5.55
Long-Term Debt Repaid	-8.22	-1.32	-0.88	-
Net Long-Term Debt Issued (Repaid)	11.19	11.8	8.2	5.55
Issuance of Common Stock	17.44	-	-	-
Net Common Stock Issued (Repurchased)	17.44	-	-	-
Issuance of Preferred Stock	-	-	2.65	-
Net Preferred Stock Issued (Repurchased)	-	-	2.65	-
Other Financing Activities	-1.56	-0.06	-0.01	-0.03
Financing Cash Flow	27.08	11.74	10.84	5.52
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.05	-0.02	-0.11	0.13
Net Cash Flow	11.36	-0.15	0.09	-5.1
Free Cash Flow	-15.67	-11.87	-10.64	-10.75
FCF Margin	-317.27%	-270.42%	-211.01%	-261.42%
Free Cash Flow Per Share	-0.43	-1.49	-1.34	-1.92
Levered Free Cash Flow	-18.73	-10.87	-6.2	-8.74
Unlevered Free Cash Flow	-16.19	-12.63	-11.9	-12.7

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q